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the more established hypothermic conditions that in any 
case tend to come about by default). We completed our 
ongoing study of the effects of normothermic systemic 
perfusion on other organ systems 2-s but no longer use it 
routinely. 
The best "comic operas" need an element of tragedy. It 
often lies in the fact that the protagonists do not know 
whether and how much they agree. 
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Can you top this? 
To the Editor." 
On the order of "Can you top this?," I place in the 
running for the longest recorded functioning bioprosthesis 
a Medtronic porcine bioprosthesis (Medtronic, Inc., Min- 
neapolis, Minn.), which was implanted in a Catholic priest 
on March 22, 1976, by Dr. Duvoisin of Spokane, Wash- 
ington. This bioprosthesis was replaced on December 5, 
1995, after 19 years and 258 days. At the second opera- 
tion, we found two of the three leaflets to be surprisingly 
intact, with only minimal calcification; the third leaflet had 
torn at the site of more dense calcification at the post. As 
the patient was only 52 years old at the time of this 
reoperation. I replaced the valve with an aortic homograft 
root. 
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